Radiosensitizer
Showing 1 - 25 of 90
Head and Neck Squamous Cell Carcinoma, Radiotherapy, Radiosensitizer Trial in China (Pirfenidone, Placebo)
Recruiting
- Head and Neck Squamous Cell Carcinoma
- +3 more
- Pirfenidone
- Placebo
-
Guangzhou, Guangdong, China
- +4 more
Nov 16, 2023
Nasopharyngeal Carcinoma, Recurrent Cancer Trial in Guangzhou (Tranilast)
Recruiting
- Nasopharyngeal Carcinoma
- Recurrent Cancer
-
Guangzhou, Guangdong, ChinaSouthern medical university
Nov 15, 2022
Brain Metastases Trial in Lebanon (Hyperbaric oxygen given at 2.4 ATA for 30 minutes immediately prior to SRS - HBOT for 30
Completed
- Brain Metastases
- Hyperbaric oxygen given at 2.4 ATA for 30 minutes immediately prior to SRS - HBOT for 30 minutes - SRS without prior HBO
-
Lebanon, New HampshireDartmouth-Hitchcock
Jan 19, 2022
Head Neck Cancer, Recurrent Cancer Trial in Guangzhou (Penicillamine)
Not yet recruiting
- Head and Neck Cancer
- Recurrent Cancer
-
Guangzhou, Guangdong, ChinaSouthern medical university
Oct 24, 2023
Locally Advanced Head and Neck HPV Negative Squamous Cell Cancers Trial in Worldwide (Cisplatin, Radiotherapy, Placebo)
Active, not recruiting
- Locally Advanced Head and Neck HPV Negative Squamous Cell Cancers
- Cisplatin
- +3 more
-
Brisbane, Australia
- +18 more
Jul 15, 2020
Cervical Cancer, Stage IIB Trial (Curcumin, Placebo oral tablet)
Withdrawn
- Cervical Cancer, Stage IIB
- Curcumin
- Placebo oral tablet
- (no location specified)
Dec 5, 2022
Head and Neck Squamous Cell Carcinoma, Hypofractionation, Radiotherapy Trial (HYpofractionated, Dose-redistributed RAdiotherapy
Recruiting
- Head and Neck Squamous Cell Carcinoma
- +4 more
- HYpofractionated, Dose-redistributed RAdiotherapy (HYDRA)
- conventional fractionated radiotherapy
-
Rotterdam, Zuid Holland, NetherlandsErasmus MC
Dec 7, 2022
Neuroendocrine Tumors, Peptide Receptor Radionuclide Therapy Trial in Rotterdam (olaparib)
Recruiting
- Neuroendocrine Tumors
- Peptide Receptor Radionuclide Therapy
-
Rotterdam, South Holland, NetherlandsErasmus MC
May 19, 2023
Oligometastases Trial in Baltimore (Nelfinavir, Stereotactic Body Radiation (SBRT))
Completed
- Oligometastases
- Nelfinavir
- Stereotactic Body Radiation (SBRT)
-
Baltimore, MarylandThe Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jun 14, 2021
dataBase for Analysis of Rectal Cancer Oncological Results
Recruiting
- Rectal Cancer
- +4 more
-
Krakow, Malopolska, Poland1st Department of General Surgery
Jul 3, 2022
Cervical Cancer Trial (Curcumin, Palliative radiotherapy)
Not yet recruiting
- Cervical Cancer
- Curcumin
- Palliative radiotherapy
- (no location specified)
Jul 14, 2023
Colon Cancer, Rectal Cancer, Liver Metastases Trial in San Francisco (Tas-102, SIR-Sphere)
Completed
- Colon Cancer
- +2 more
- Tas-102
- SIR-Sphere
-
San Francisco, CaliforniaUniversity of California San Francisco
Jul 28, 2022
Locally Advanced Pancreatic Cancer Trial in Washington, Baltimore (Gemcitabine, Hypofractionated Ablative Proton Therapy)
Recruiting
- Locally Advanced Pancreatic Cancer
- Gemcitabine
- Hypofractionated Ablative Proton Therapy
-
Washington, District of Columbia
- +1 more
Oct 10, 2022
Squamous Cell Carcinoma of Head and Neck Trial in Aurora (sEphB4-HSA with chemo, Cetuximab, Radiation Therapy)
Completed
- Squamous Cell Carcinoma of Head and Neck
- sEphB4-HSA with chemotherapy
- +2 more
-
Aurora, ColoradoUniversity of Colorado Hospital
Dec 9, 2022
Diffuse Intrinsic Pontine Glioma, Anaplastic Astrocytoma, High Grade Glioma Trial run by the NCI (Lenalidomide, XRT, 54-59.4 Gy)
Completed
- Diffuse Intrinsic Pontine Glioma
- +2 more
- Lenalidomide
- XRT, 54-59.4 Gy
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 30, 2021
Recurrent Cancer, Prostate Cancer, Cervical Cancer Trial in Berlin (loco-regional hyperthermia)
Recruiting
- Recurrent Cancer
- +9 more
- loco-regional hyperthermia
-
Berlin, GermanyKlinik für Radioonkologie und Strahlentherapie
May 12, 2021
Neuroendocrine Tumors, Gastro Entero Pancreatic Neuroendocrine Tumors Trial in Meldola, Milan (28 GBq 177Lu-DOTATATE, 22 GBq
Active, not recruiting
- Neuroendocrine Tumors
- Gastro Entero Pancreatic Neuroendocrine Tumors
- 28 GBq 177Lu-DOTATATE
- 22 GBq 177Lu-DOTATATE
-
Meldola, FC, Italy
- +1 more
Feb 25, 2021
Resectable Pancreatic Cancer, Adjuvant Chemoradiotherapy, Surgery Trial in Shanghai (other, drug, radiation)
Recruiting
- Resectable Pancreatic Cancer
- +2 more
- Follow-up only
- +3 more
-
Shanghai, Shanghai, ChinaZhongshan Hospital Fudan University
Feb 1, 2021
Oncology Trial in Nijmegen (combined aerobic exercise + resistance exercise intervention (AE + RE), Aerobic exercise prior to
Recruiting
- Oncology
- combined aerobic exercise + resistance exercise intervention (AE + RE)
- Aerobic exercise prior to daily radiotherapy sessions (ExPR)
-
Nijmegen, Gelderland, NetherlandsRadboud Institute for Health Science
Jan 8, 2023
Hyperthermia Trial in Seoul (Combined hyperthermia and radiation therapy)
Terminated
- Hyperthermia
- Combined hyperthermia and radiation therapy
-
Seoul, Korea, Republic ofSamsung Medical Center
Mar 18, 2020
Endometrial Tumors Trial in Worldwide (biological, drug, radiation)
Recruiting
- Endometrial Neoplasms
- Pembrolizumab
- +8 more
-
Birmingham, Alabama
- +228 more
Jul 29, 2022
Glioblastoma Trial in Münster (Gliolan, Radiodynamic therapy)
Recruiting
- Glioblastoma
- Gliolan
- Radiodynamic therapy
-
Münster, GermanyUniversity Hospital Münster, Klinik für Neurochirurgie
Nov 16, 2022